ras p21 Expression in the progression of breast cancer
Authors:
- Michael V. ViolaMVMichael V. Viola
- Sylvia ChaoSCSylvia Chao
- Sheila OravezSOSheila Oravez
- Yousri MishrikiYMYousri Mishriki
- Gerald FinkelGFGerald Finkel
- Roger GrimsonRGRoger Grimson
- Joel LundyJLJoel Lundy
Open Access
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 18 (12) , 1268-1275
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasmsBritish Journal of Cancer, 1985
- Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors.Proceedings of the National Academy of Sciences, 1985
- ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.Journal of Experimental Medicine, 1985
- Expression of p21ras in fresh primary and metastatic human colorectal tumors.Proceedings of the National Academy of Sciences, 1985
- Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseasesNature, 1984
- Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.Proceedings of the National Academy of Sciences, 1984
- Expression of Cellular Oncogenes in Human MalignanciesScience, 1984
- Oncogenes in solid human tumoursNature, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinomaAmerican Journal of Surgical Pathology, 1977